Top Markets
Coin of the day
Sinew Pharma Inc. Sinew Pharma Inc.

Sinew Pharma Inc.

6634
株式のランク #20226
Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research,... Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research, development, and commercialization of new therapeutics. Its core mission revolves around pioneering innovative solutions for hepatotoxicity-free acetaminophen and addressing various fatty liver conditions. The company's robust pipeline features SNP-610, a drug candidate currently advancing through Phase II clinical trials in Taiwan for the treatment of non-alcoholic steatohepatitis (NASH). Another early-stage compound, SNP-630, is also in preclinical development, targeting NASH. Beyond liver disease, Sinew Pharma is progressing SNP-810 for its analgesic and antipyretic properties. Furthermore, the firm is developing SNP-830 and SNP-840, positioned as liver-safe pain medications specifically for the United States market. Established in 2014, Sinew Pharma Inc. maintains its headquarters in Taipei City, Taiwan.
株価
$1.91
時価総額
$136.47M
変化(1日)
-1.15%
変化(1年)
21.17%
TW
取引 Sinew Pharma Inc. (6634)

カテゴリー

Sinew Pharma Inc.(6634)の配当利回りの履歴
Sinew Pharma Inc.(銘柄コード: 6634)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Sinew Pharma Inc.(6634)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)